DILIGENCE · WHAT WE SEND YOU

The Due-DiligencePackage.

Serious partners ask for the file before they ask for terms. This page states exactly what Continuum Innovative provides for scientific and commercial review, what is provided openly, and what requires confidentiality.

The intention is that a licensing, distribution or investment committee can reach a defensible go/no-go decision without a protracted discovery process.

PEER-REVIEWED PUBLICATIONS

PATENT-PENDING PROGRAMS

25+

YEARS OF COMMERCIAL RECORD

EVALUATION DIMENSIONS APPLIED

PROVIDED OPENLY

Available without an NDA.

Everything in this first tier is either already public or publishable. A partner can begin evaluation immediately.

Peer-reviewed literature

Full citations and links for the five published papers underpinning mechanism, delivery and clinical observation. Publications.

Mechanism documentation

How botanical 5α-reductase inhibition, anti-inflammatory signaling and β-cyclodextrin delivery are proposed to act. Research programs.

IP program summaries

Scope and subject matter of the six patent-pending programs, described as provisional applications rather than issued patents. Intellectual property.

Commercial record

The GCC distribution history and the brands' commercial trajectory. Commercial impact.

Product and brand material

Product architecture, positioning and consumer-facing evidence for HairGenesis® and TrichoCyte™.

Founder credentials

Three decades of research, editorial and review history. Dr. Geno Marcovici.

PROVIDED UNDER CONFIDENTIALITY

The second tier.

Once a partner has established genuine intent — a defined territory, channel and commercial thesis — the confidential tier opens. This is where formulation specifics, filing detail and commercial structure are discussed.

We do not circulate this material speculatively, and we do not quote commercial terms publicly. Terms are always specific to territory, channel, volume and structure.

Provisional filing detail — scope, priority dates and claim direction of the six programs.
Formulation and technical files — composition, specification and manufacturing documentation.
Claim-substantiation material — the evidence mapping behind each proposed marketing claim.
Commercial structure — territory, exclusivity conditions, and the shape of the agreement.

HOW WE SUGGEST YOU EVALUATE IT

Use a framework, not an impression.

Continuum publishes the methodology it uses when evaluating third-party technologies, and we are content to be judged by it. The Continuum Translational Assessment Framework™ assesses an asset across nine dimensions — mechanism plausibility, evidence quality, delivery feasibility, intellectual-property substance, claim defensibility, manufacturability, regulatory realism, commercial durability and portfolio fit.

If your committee applies those nine dimensions to this portfolio, the answer you reach will be the right one — in either direction. That is preferable to a decision made on presentation quality.

III

TIMELINE

What a normal process looks like.

Days 1–2 — open material.

You receive the publications, mechanism documentation, IP summaries and commercial record. No NDA required.

Week 1 — scientific call.

Direct discussion with the founder and principal investigator. Mechanism, evidence limits and delivery are addressed candidly, including what the evidence does not establish.

Week 2 — confidential tier.

Under NDA: formulation, technical files, filing detail, claim substantiation and proposed commercial structure.

Week 3 onward — structure.

Distribution, license, co-development or strategic investment, drafted around your organization's actual capability.

Partnership pathwaysAll available relationship structures.Licensing & distribution FAQDirect answers to first-order questions.The Assessment Framework™The nine dimensions we apply.PublicationsThe peer-reviewed record.Intellectual propertyThe six patent-pending programs.Strategic investmentFor capital partners with commercial capability.

NEXT STEP

Ask for the file.

State your organization, territory and the structure you are considering. The open tier goes out the same week.

REQUEST THE DILIGENCE PACKAGE